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Progression through the G1/S transition commits cells to synthesize DNA. Cyclin dependent
kinase 2 (CDK2) is the major kinase that allows progression through G1/S phase and subsequent
replication events. p27 is a CDK inhibitor (CKI) that binds to CDK2 to prevent premature
activation of this kinase. Speedy (Spy1), a novel cell cycle regulatory protein, has been found to
prematurely activate CDK2 when microinjected into Xenopus oocytes and when expressed in
mammalian cells. To determine the mechanism underlying Spy1-induced proliferation in mam-
malian cell cycle regulation, we used human Spy1 as bait in a yeast two-hybrid screen to identify
interacting proteins. One of the proteins isolated was p27; this novel interaction was confirmed
both in vitro, using bacterially expressed and in vitro translated proteins, and in vivo, through the
examination of endogenous and transfected proteins in mammalian cells. We demonstrate that
Spy1 expression can overcome a p27-induced cell cycle arrest to allow for DNA synthesis and
CDK2 histone H1 kinase activity. In addition, we utilized p27-null cells to demonstrate that the
proliferative effect of Spy1 depends on the presence of endogenous p27. Our data suggest that
Spy1 associates with p27 to promote cell cycle progression through the G1/S transition.
INTRODUCTION
Cell cycle progression is regulated by the activity of cyclin-
dependent kinases (CDKs). CDK activity is dependent on
interactions with their regulatory subunits called cyclins
(Sherr, 1994; Morgan, 1995, Sherr and Roberts, 1999). At the
G1/S transition of the cell cycle, cyclin D, cyclin E, and cyclin
A associate with CDKs to promote cell cycle progression.
Particularly important at the G1/S transition is the activation
of cyclin E/CDK2, which is necessary for DNA replication.
CDK activity is also dependent on phosphorylation events.
To activate CDK2, the cdc25 phosphatases remove two in-
hibitory phosphates on Thr 14 and Tyr 15 and cyclin acti-
vating kinase (CAK) phosphorylates CDK2 at Thr 160. Phos-
phorylation of Thr 160 is especially important for CDK
activation, because it is believed to promote additional con-
formational changes that may expose the catalytic cleft for
substrate binding (Jeffrey et al., 1995). CDK regulation is also
mediated in part by the cyclin-dependent kinase inhibitors
(CKIs), which bind to cyclin/CDK complexes and inhibit
CDK activity. There are two CKI families: Cip/Kip, which
includes p21Cip1, p27Kip1, and p57Kip2, and INK4, which
includes p16INK4a, p15INK4b, p18INK4c, and p19INK4d. p27Kip1
interaction with cyclin E/CDK2 prevents premature entry
into S phase (Nakayama et al., 2001).
Normally, p27Kip1 protein levels are high during G0 and
G1 phases of the cell cycle, resulting in cyclin/CDK inhibi-
tion. In addition, p27 protein expression can be stimulated in
other phases of the cell cycle by contact inhibition, mitogen
withdrawal, differentiation signals, or other antiproliferative
cues that result in G1 arrest (Koff et al., 1993; Polyak et al.,
1994; Slingerland et al., 1994; Toyoshima and Hunter, 1994;
Durand et al., 1997; Baldassarre et al., 2000). p27 has been
found to associate with cyclin A/CDK2, cyclin E/CDK2,
and cyclin D/CDK4,6 (Slingerland and Pagano, 2000). When
mitogens are present, cyclin D/CDK4 forms a trimeric com-
plex with p27 that results in less p27 available to inhibit
cyclin E/CDK2. Interestingly, one of the substrates of cyclin
E/CDK2 is p27, which is phosphorylated on Thr 187 as a
result of activated CDK2. Phosphorylation at Thr 187 targets
p27 for degradation via the SCFSkp2 ubiquitin ligase path-
way (Pagano et al., 1995; Shaeff et al., 1997; Vlach et al., 1997;
Carrano et al., 1999; Montagnoli et al., 1999, Sutterluty et al.,
1999; Tsvetkov et al., 1999). Decreasing protein levels of p27
results in cell cycle progression through the G1/S transition.
Human Spy1 is a novel cell cycle regulator found to bind
and activate CDK2 histone H1 kinase activity (Porter et al.,
2002). Spy1 mRNA is expressed during G1/S phase in a
variety of human tissues and cell lines such as 293T and
NTERA-2 cells (Porter et al., 2002). In these cell lines, Spy1
enhances cell proliferation by shortening G1 phase in a man-
ner that is dependent on CDK2 kinase activity. Small inter-
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fering RNA (siRNA) directed against Spy1 demonstrates
that Spy1 is an essential regulator of cell cycle progression.
Taken together, these data indicate that Spy1 regulates cell
cycle progression through activation of CDK2.
In this study, we sought to determine the mechanism by
which Spy1 regulates cell cycle progression. Toward this
end, we used a yeast two-hybrid screen using full-length
human Spy1 as bait to identify other proteins that may be
interacting with Spy1. One of the clones isolated was p27.
We have confirmed this interaction using various in vitro
and in vivo binding assays. Interestingly, CDK2 binding to
Spy1 is enhanced in the presence of p27. Functionally, when
Spy1 is coexpressed with p27 compared with cells express-
ing p27 alone, there is an increase in the number of cells in
S phase and enhanced CDK2 kinase activity. This indicates
that Spy1 can overcome p27-mediated growth arrest. In
addition, we demonstrate that Spy1-enhanced proliferation
depends on the presence of endogenous p27. Our data sug-
gest that Spy1 enhances cell cycle progression by preventing
the inhibitory actions of p27 on CDK2.
MATERIALS AND METHODS
Two-hybrid Constructs
The two-hybrid plasmids pBTM116 (constructed by P. Bartel and S.
Fields), pVP16, and pLexA-lamin (Vojtek et al., 1993; Vojtek and
Hollenberg, 1995) were generous gifts from S. Hollenberg and J.A.
Cooper (Fred Hutchinson Cancer Research Center). LexA-Spy1 was
constructed by first inserting oligos D2421/D2422 into pSP64-Spy1
(pJT013; Porter et al., 2002) via EcoRI and NsiI sites to generate a
BamHI site preceding the start site of human Spy1 (pMK64). The
pBTM116 vector was digested with BamHI and PstI; pMK64 was
digested with BamHI and NsiI. The pBTM116 vector and Spy1
fragment were then ligated to produce LexA-Spy1 (pMK65).
Two-hybrid Screen
The two-hybrid screen was performed according to previously pub-
lished protocols (Vojtek et al., 1993; Vojtek and Hollenberg, 1995) .
LexA-Spy1 was cotransformed with a 9.5 dpc mouse embryo cDNA
library fused to pVP16 into the L40 strain of Saccharomyces cerevisiae.
The transformants were selected on His plates for 3–4 d at 30°C
with the addition of 2.5 mM 3-aminotriazole (3-AT; Sigma, St. Louis,
MO). An interaction was scored positive for the ability of the yeast
to grow beyond bait plus empty pVP16 vector and to overcome
3-AT inhibition. A -galactosidase filter-lift assay was also per-
formed to confirm a positive interaction. False positives were dis-
criminated by testing cDNA-pVP16 against LexA-lamin. The re-
maining cDNA-pVP16 clones were then shuttled into Escherichia coli
HB101 cells, rescued, and then sequenced in the Core facility at the
UCSD Cancer Center. The sequences were then entered into the
NCBI BLAST program for identification.
Plasmid Construction
Flag-tagged Spy1 was constructed by first adding a BglII site by
QuikChange site-directed mutagenesis (Stratagene, La Jolla, CA)
downstream of the NdeI site of human Spy1 in pJT013. Oligonucle-
otides (D2479/D2480) containing the flag tag were synthesized and
inserted between NdeI and BglII sites of pJT013. This construct was
then digested with EcoRI and XhoI and inserted into the pLXSN
vector at the same sites. Finally, the flag-tagged Spy1 gene was
cloned into pcDNA3 via EcoRI and BamHI. Myc-tagged Spy1 was
constructed as previously described (Porter et al., 2002).
The p27 clones isolated from the two-hybrid screen were sub-
cloned from the pVP16 vector to the pCS3MT vector to produce
myc-tagged p27. First, oligonucleotides D2541/D2542 were inserted
between the NcoI and BamHI sites in pCS3MT to make the p27
clones in-frame with the myc tags (pMK92). p2723–128 and 2732–162
were digested with BamHI and EcoRI and each fragment was in-
serted into the modified pCS3MT vector via BglII and EcoRI sites
to produce pMK93–3 and pMK93–4, respectively. myc-p2725–51 was
constructed by digesting pMK92 with BglII and EcoRI to insert
oligos D2564/D2565 containing the mouse cyclin-binding region of
p27 to produce pMK94. myc-p2743–128 was constructed by digesting
pCS3MT vector with NcoI and EcoRI and inserting oligos D2566/
D2567 containing a unique SmaI site to produce pMK95. pMK95 and
pMK93-3 were then digested with SmaI and XbaI. The vector from
pMK95 was ligated with the fragment from pMK93-3 (containing
the CDK-binding region of p27) to produce pMK96.
Cell Lines
p27 null immortalized MEFs (MEF/) from 129/sv  C57BL/6
hybrid mice were obtained from Jim Roberts and were previously
described (Cheng et al., 1999). p27 null NIH3T3 (3T3/) cells were
obtained from Andrew Koff and are previously described (Vidal et
al., 2002). Both 293T and MEF/ were cultured in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with 10% fetal
bovine serum (FBS) and incubated at 37°C in 10% CO2. COS-1 cells
were maintained in DMEM supplemented with 10% FBS at 37°C in
5% CO2. NIH3T3 and 3T3/ cells were cultured in DMEM sup-
plemented with 10% calf serum at 37°C in 10% CO2.
Coimmunoprecipitation and Immunoblotting
Subconfluent 293T cells were transfected with 2.5 g of p27 and/or
Spy1 by the calcium phosphate precipitation method (Chen and
Okayama, 1987) in a 10-cm dish. Additional empty pcDNA3 vector
was added to produce a total of 5 g DNA transfected into each
dish. Twenty-four hours after transfection, cells were harvested and
lysed in 0.5% NP-40 lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl,
0.5% NP-40, 1 mM Na3VO4, 1 mM NaF, 1 mM DTT, 1 mM PMSF, 10
g/ml aprotinin, 10 g/ml pepstatin A, and 10 g/ml leupeptin).
Lysates (1 mg protein) were precleared with 40 l Protein A-Sepha-
rose beads and incubated with 2 g of -flag (Sigma), -myc (9E10;
Santa Cruz Biotechnology, Santa Cruz, CA), -p27 (Zymed, South
San Francisco, CA, or Santa Cruz) or -CDK2 (Santa Cruz) over-
night at 4°C. For the endogenous Spy1 interaction with endogenous
p27, 293T cells were lysed in 0.1% NP-40 lysis buffer and 6 mg of
lysate was immunoprecipitated with -p27 sera (Zymed) or -Spy1
sera as previously described by Porter et al. (2002). Protein A-
Sepharose beads were then added for at least 2 h, and the immu-
noprecipitated samples were washed three times, boiled 5 min in
sample buffer, and then analyzed on 10% SDS-PAGE. Half of each
immunoprecipitate and 50 g of lysate were loaded into the gels.
The gels were then transferred to nitrocellulose membrane, immu-
noblotted with 1:2000 -p27 (Santa Cruz Biotechnology, Santa Cruz,
CA), 1:2000 -CDK2, 1:4000 -myc (9E10), 1:2000 -flag (Sigma), or
1:500 -Spy1 followed by ECL (Amersham, San Francisco, CA).
When it was necessary to reprobe with other antibodies recognizing
proteins of similar molecular weight, the membranes were stripped
of bound antibodies in stripping buffer (100 mM 2-mercaptoethanol,
2% SDS, 62.5 mM Tris-HCl, pH 6.8) and incubated for 30 min at
60°C with rotation.
In Vitro Binding Assay
p27-pGEX2T was obtained from Makoto Nakanishi (Morisaki et al.,
1997). GST-p27 and GST control proteins were purified using stan-
dard methods (Nakanishi et al., 1995). Briefly, a single colony of the
pGEX transformant was grown in 100 ml LB/ampicillin medium for
15 h at 37°C. This culture was then diluted 1:10 into 1 liter fresh
media for 2 h at 37°C followed by the addition of 1 mm IPTG for 4 h
at 30°C. Cells were collected in 20 ml ice-cold PBS containing 1%
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NP-40, 10 mM DTT, 1 mM PMSF, 10 g/ml aprotinin, and 10 g/ml
leupeptin and sonicated using a 5-mm-diameter probe for 30 s.
Triton X-100 (10%) was added to 1% and mixed, and insoluble
material was removed via centrifugation. One milliliter of 50%
glutathione-agarose beads (Sigma) was added to the supernatant
and mixed gently for 1 h at 4°C. Beads were then collected via
centrifugation and washed three times in 50 ml of ice-cold PBS.
In vitro–translated proteins were produced using an SP6-coupled
rabbit reticulocyte lysate system (Promega, Madison, WI), with the
procedures performed as described by the manufacturer.
Both in vitro–translated and GST protein products were first
analyzed by SDS-PAGE and then binding assays were carried out in
200 l of binding buffer (50 mM K2HPO4, 150 mM KCl, 1 mM
MgCl2, 10% [vol/vol] glycerol, 1% [vol/vol] Triton X-100, 1 mM
PMSF, 10 g/ml aprotinin, and 10 g/ml leupeptin). Binding in-
teractions were incubated at 4°C with gently rotation for 2 h,
washed three times with binding buffer, boiled 5 min in 2 sample
buffer, and then analyzed by SDS-PAGE.
In Vitro Kinase Assay
293T cells were transfected as described above. Twenty-four to 36 h
after transfection the cells were harvested with 0.5% NP-40 lysis
buffer. Each sample was immunoprecipitated with -CDK2 sera
overnight at 4°C with rotation. Protein A-Sepharose beads were
added for 2 h with rotation and then subjected to an in vitro kinase
assay as previously described (Kong et al., 2000).
Immunofluorescence Microscopy
For Spy1 and p27 localization studies, COS-1 cells were plated onto
glass coverslips and cultured as described above. Cells were tran-
siently transfected with 10 g of DNA in a 60-mm dish. Cells were
then fixed with 3% paraformaldehyde in phosphate-buffered saline
(PBS) for 15 min and permeabilized with 0.1% Triton X-100 for 10
min. Cells were blocked with 3% BSA for 30 min and then incubated
with -p27 (1:500) antibody for 1 h, washed, and incubated for 30
min with 1:500 rhodamine-conjugated goat anti-rabbit IgG (Boehr-
inger Mannheim, Indianapolis, IN). To detect myc-Spy1, -myc
(9E10) antibody (1:500) was added for 1 h, washed, and visualized
with FITC-conjugated goat anti-mouse secondary antibody (Boehr-
inger Mannheim). Coverslips were mounted on glass slides with
100 mM Tris, pH 8.0, 90% glycerol, 1 mg/ml phenylenediamine,
and 1 g/ml Hoechst dye 33342 to detect DNA.
For analysis of 4-bromodeoxyuridine (BrdU) incorporation,
NIH3T3 cells were plated onto glass coverslips and cultured as
described above. Cells were transiently transfected with a total of
10.1 g of DNA (0.1 g GFP, 5 g p27, 5 g flag-Spy1). pcDNA3
was added to single transfections to bring the final DNA concen-
tration to 10.1 g. Eighteen hours after transfection, the medium
was replaced and incubated at 10% CO2, BrdU (100 L of 6 mg/ml;
Sigma) was added to the cells for 2 h. The cells were then fixed as
described above. To visualize BrdU incorporation, 1:50 -BrdU
mouse sera (Becton Dickinson, Palo Alto, CA) was added for 1 h to
cells, washed, and incubated with 1:50 -rhodamine–conjugated
anti-mouse (Boehringer-Mannheim). One hundred GFP-positive
cells were then counted from each coverslip and scored for BrdU
incorporation. Three independent experiments were performed
with similar results, and the SE of the mean is presented.
Cell Proliferation Assay
To determine the effect of Spy1 on cells lacking endogenous p27, 1
105 MEF/ cells were seeded onto 10-cm dishes and cultured as
described above. Twenty-four hours after seeding, cells were tran-
siently transfected in triplicate with a total of 10 g of DNA, and
pcDNA3 was added to single transfections to make up the differ-
ence. Eighteen hours after transfection, the medium was replaced
and incubated at 10% CO2 for 24 h. The cells were then trypsinized
and live cells were counted via trypan blue exclusion. Four counts
were made for each triplicate transfection. Four independent exper-
iments were performed with similar results, and the SE of the mean
is presented.
CDK2-Spy1 Binding Assay
NIH3T3 cells or equivalent cells null for p27 (3T3/) were seeded
on 150-mm plates at 6  105 cells/plate, and 24 h after seeding cells
were harvested and lysed as described above. Lysates (containing 3
mg of protein) were incubated with 6 g of -p27 (Santa Cruz),
-CDK2 (Santa Cruz), or -Spy1 sera as previously described by
Porter et al. (2002) overnight at 4°C. Protein A-Sepharose beads were
then added for 2 h, and the immunoprecipitated samples were
washed three times, boiled 5 min in sample buffer, and then ana-
lyzed by 10% SDS-PAGE as described above.
RESULTS
Two-Hybrid Interaction between p27 and Spy1
We performed a yeast two-hybrid screen using LexA-Spy1
as bait against a 9.5 dpc mouse embryo library, which re-
sulted in 103 positives. DNA sequencing of the mouse
cDNA inserts revealed that several of these proteins had
been pulled out at least twice. After subjecting the clones to
a -galactosidase filter-lift assay and a false-positive test by
interaction against LexA-lamin, 33 clones were identified as
positive interactors. One of the clones identified was the
CDK inhibitor, p27 (Table 1). As shown in Figure 1, two
clones were isolated from the two-hybrid screen. One of the
clones included aa 23–128 of mouse p27, and the second
clone included aa 32–162 of mouse p27. Both of the mouse
p27 clones isolated from the two-hybrid screen encom-
passed the cyclin-binding and CDK-binding regions of p27.
p2732–162 also included a large portion of the nuclear local-
ization signal (NLS) of p27.
The CDK Binding Region of p27 Interacts with Spy1
In Vivo
We constructed myc-tagged p27 derivatives (p2723–128 and
p2732–162) to investigate whether these portions of p27 could






LexA-Spy1   
LexA-lamin   
Figure 1. Schematic representation of p27. Full-length p27 con-
tains a cyclin-binding region (aa 25–51), a CDK-binding region (aa
53–93), and a nuclear localization signal (NLS; aa 152–166). The two
clones isolated from the yeast two-hybrid screen encompassed aa
23–128 of p27 (middle) and aa 32–162 of p27 (bottom).
L.A. Porter et al.
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interact with Spy1 in mammalian cells. 293T cells were
transfected with mock, flag-tagged Spy1, myc-p2723–128,
myc-p2732–162, and flag-Spy1 plus myc-p2723–128 or myc-
p2732–162. Lysates were then immunoprecipitated with the
myc antisera, separated by 10% SDS-PAGE, and transferred
to nitrocellulose membrane. The membrane was then
probed with -flag sera to detect Spy1. In Figure 2A (lanes
11 and 12), we show that Spy1 can interact with both myc-
p2723–128 and myc-p2732–162. The bottom panel of Figure 2A
indicates approximately equal levels of myc-p27.
To further delineate the interaction of Spy1 with p27,
separate myc-tagged clones of p27 were constructed com-
prised of either the cyclin-binding region or the CDK-bind-
ing regions of p27. Each clone was transfected with or with-
out flag-Spy1 and immunoprecipitated with -myc sera.
Myc-p2725–51, which is the cyclin-binding region of mouse
p27, did not interact with flag-Spy1 (Figure 2B, lane 11). In
contrast, myc-p2743-128, which encompasses the CDK-bind-
ing region of p27, interacted with flag-Spy1 (Figure 2B, top
panel, lane 12). The data suggest that Spy1 binds to the
CDK-binding region, but not the cyclin-binding region, of
p27.
p27 Interacts with Spy1 In Vitro
To confirm an in vitro interaction between p27 and Spy1, we
first in vitro translated p27 (TNT-p27), myc-tagged Spy1
(TNT-Spy1), and pCS3MT empty vector (TNT-mock) us-
ing a SP6-coupled rabbit reticulocyte lysate system. After a
2-h incubation of TNT-p27 with either TNT-Spy1 or TNT-
mock (Figure 3A), TNT-p27 selectively immunoprecipitated
with TNT-Spy1 but not with the TNT-mock control (Figure
3A, bottom panel). As an additional control, we immuno-
blotted the in vitro–translated proteins with CDK2 antisera
to determine if there were trace levels of CDK2 protein in the
reticulocyte lysate. As seen in Figure 3B, there is no CDK2
protein that can be detected within the limit of Western blot
analysis.
Next, we determined whether TNT-Spy1 would also bind
to bacterially produced GST-p27. We purified both GST-p27
fusion proteins and GST control proteins using standard
methods and conjugated the bacterial proteins to GST beads.
To rigorously ensure that CDK2 protein, possibly existing at
undetectable levels in the reticulocyte lysate, was not play-
ing a role in the p27-Spy1 interaction, we also immunode-
pleted both TNT-Spy1 and TNT-mock products with CDK2
antisera before binding. Figure 3C demonstrates that after a
2-h incubation with GST control (middle panel, lanes 1 and
2) or GST-p27 (middle panel, lanes 3 and 4), TNT-Spy1
selectively bound to GST-p27 and not to the GST control
(bottom panel, lane 4 compared with lane 2).
Full-length p27 Interacts with Spy1
We next confirmed the interaction between full-length hu-
man p27 and Spy1 by coimmunoprecipitation in mamma-
lian cells. 293T cells were transfected with mock, full-length
p27 (untagged), myc-tagged Spy1, or both p27 and myc-
Spy1. Precleared cell lysates were then subjected to immu-
noprecipitation by -p27 sera, analyzed by 10% SDS-PAGE,
transferred to nitrocellulose membrane, and immunoblotted
with -p27 or -myc sera. The top panel of Figure 4A shows
that myc-Spy1 can coimmunoprecipitate with p27 (lane 8).
The bottom panel of Figure 4A confirms approximately
equal levels of transfected p27. The data also indicate that
endogenous p27 levels are low as expected in these cycling
cells, requiring the transfection of exogenous p27 to visual-
ize the protein. Thus, full-length p27 can interact with Spy1.
We examined 293T cells transfected with or without flag-
tagged Spy1 followed by serum starvation overnight with
0.2% FBS to induce p27 expression. The top panel of Figure
4B shows that flag-Spy1 coimmunoprecipitates with endog-
enous p27 (lane 4). Immunoblotting with -p27 sera shows
the presence of endogenous p27 in the -p27 immunopre-
cipitated samples (Figure 4B, bottom panel). Protein
A-Sepharose beads alone were used as a negative control
(lanes 5 and 6). We also examined the interaction of endog-
enous Spy1 and endogenous p27. Lysates from starved cells
Figure 2. Spy1 interacts in vivo with the mouse p27 clones isolated
from the two-hybrid screen. (A) 293T cells were transiently trans-
fected with the indicated constructs, lysed, immunoprecipitated
with -myc sera, analyzed by 10% SDS-PAGE, and transferred to
nitrocellulose membrane. The membrane was then immunoblotted
with -flag sera to detect flag-tagged Spy1 (top panel). As shown in
lanes 11 and 12 of the top panel, flag-Spy1 coimmunoprecipitates
with myc-p2723–128 and myc-p2732–162, respectively. The membrane
was then stripped and reprobed with -myc sera to demonstrate the
presence of the myc-tagged p27 constructs (bottom panel). (B) 293T
cells were transfected with the indicated constructs, lysed, immu-
noprecipitated with -myc sera, and analyzed as above. Myc-p27
25–51, which is the cyclin-binding region of p27, did not appear to
bind to flag-Spy1 (lane 11). In contrast, myc-p27 43–128, which en-
compasses the CDK-binding region of p27, interacted with flag-
Spy1 (lane 12).
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Figure 3. Human p27 interacts with human Spy1 in vitro. (A) In vitro–
translated p27 (TNT-p27) was incubated for 2 h with either in vitro–
translated pCS3-MT empty vector (TNT-mock) or in vitro–translated myc-
tagged Spy1 (TNT-Spy1). The top panel demonstrates the amount of input
TNT-Spy1 protein (lane 2), the middle panel demonstrates the input
TNT-p27 protein (lanes 1 and 2). Both samples were immunoprecipitated
with -myc sera, and proteins were separated by 10% SDS-PAGE and
immunoblotted with p27 sera (bottom panel). (B) In vitro–translated
pCS3-MT (TNT-mock), p27 (TNT-p27), myc-Spy1 (TNT-Spy1), or CDK2
(TNT-CDK2) were separated by 10% SDS-PAGE and immunoblotted
with -CDK2 sera as a control. (C) Purified GST-p27 or GST-control
protein conjugated to GST beads were incubated in binding buffer with
either in vitro–translated (TNT) mock or Spy1 protein (top panel), both of
which were previously immunodepleted for any CDK2 protein as an
additional control. A GST pull-down assay was performed. Proteins were
separated by 12.5% SDS-PAGE and immunoblotted with -myc sera to
detect immunoprecipitation of GST proteins with myc-tagged proteins
(bottom panel). -GST immunoblot is presented to demonstrate the GST
proteins present in the GST pull-down experiment. Different exposures of
the same immunoblot are presented in the middle panel because of the
high amount of protein in the GST-control lanes.
Figure 4. p27 binds to Spy1 in vivo. (A) 293T cells were transiently
transfected with the indicated constructs, lysed, immunoprecipi-
tated with -p27 sera, analyzed by 10% SDS-PAGE, and transferred
to nitrocellulose membrane. The membrane was then immuno-
blotted with -myc sera to detect myc-tagged Spy1 (top panel). As
shown in lane 8 of the top panel, p27 can coimmunoprecipitate with
myc-tagged Spy1. The bottom panel demonstrates the approxi-
mately equal expression of exogenous p27. (B) 293T cells were
transfected with mock or flag-Spy1 constructs, starved, lysed, and
immunoprecipitated with -p27 sera. Immunoblotting with -flag
sera shows that flag-Spy1 interacts with endogenous p27 (lane 4).
(C) 293T cells were starved, lysed, and immunoprecipitated with
-p27 or -Spy1 sera. Immunoblotting demonstrates that endoge-
nous Spy1 interacts with endogenous p27 (lanes 1 and 2). A sample
with no primary antibody was used as a negative control (lane 3).
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were then immunoprecipitated with -p27 sera followed by
immunoblotting with -Spy1 sera. Figure 4C demonstrates
the presence of endogenous Spy1 in the p27 immunopre-
cipitate (top panel, lane 1). Similarly, endogenous p27 coim-
munoprecipitated with endogenous Spy1 (bottom panel,
lane 2). Once again Protein A-Sepharose was immunopre-
cipitated alone as a negative control (top and bottom panel,
lane 3). Taken together, endogenous Spy1 and endogenous
p27 can interact in human cells.
Spy1 and p27 Colocalize in the Nucleus
p27 must be imported into the nucleus to inhibit CDK2
activity (Reynisdo´ttir and Massague´, 1997; Slingerland and
Pagano, 2000). This inhibition of CDK2 appears to be a
dichotomy because cyclin E/CDK2 phosphorylation of p27
on Thr 187 is a trigger for degradation of p27 (Morisaki et al.,
1997). It has been hypothesized that there may be alternate
triggers for p27 degradation that will relieve the inhibition
of CDK2 to a certain threshold, allowing for phosphoryla-
tion of p27. This would begin a feedback loop resulting in
the eventual degradation of p27 and resumption of the cell
cycle (Rodier et al., 2001). One of these pathways requires
cytoplasmic relocalization aided by Jab1 (Tomoda et al.,
1999). Because Spy1 has also been shown to be primarily
nuclear in localization, although Spy1 can undergo relocal-
ization upon DNA damage (Porter et al., 2002; unpublished
results), we wanted to determine the effect, if any, that
coexpression of Spy1 had on p27 localization. Immunofluo-
rescence studies were performed on both single- and dou-
ble-transfected COS-1 cells. As shown in Figure 5Aa, p27
and myc-Spy1 (Figure 5Ac) are each localized in the nucleus.
Cotransfection of p27 and myc-Spy1 results in the nuclear
localization of both proteins (Figure 5Bc). The data indicate
that neither p27 nor myc-Spy1 alter their nuclear localization
upon coexpression.
p27, CDK2, and Spy1 Form a Complex
Studies in our laboratory have shown that CDK2 and Spy1
form a complex (Lenormand et al., 1999, Porter et al., 2002).
To determine whether CDK2 was part of the p27/Spy1
complex, we transfected 293T cells with mock, p27, flag-
Spy1, or p27 plus flag-Spy1. The lysates were immunopre-
cipitated with -p27 sera and immunoblotted with -flag,
-CDK2, or -p27 sera. In Figure 6, lane 8, we demonstrate
that Spy1, CDK2, and p27 can form a complex. Interestingly,
immunoprecipitation with -CDK2 antibody resulted in a
significant difference in Spy1/CDK2 binding. In Figure 6,
lane 11, we demonstrate that CDK2 and Spy1 can interact
when p27 levels are low. When exogenous p27 was trans-
fected into the cells, there is an increase in the amount of
Spy1 in the complex (Figure 6, lane 12). These data suggest
that the presence of p27 increases the amount of Spy1 asso-
ciation to the p27/CDK2 complex.
Spy1 Can Overcome a p27-induced G1 Arrest
We next wanted to examine the biological effect of the in-
teraction between p27 and Spy1. Because Spy1 has been
found to enhance cell proliferation, we wanted to determine
whether Spy1 could affect a G1 arrest induced by p27 over-
expression. NIH3T3 cells were transfected with mock, p27,
flag-Spy1, or p27 plus flag-Spy1. A GFP expression vector
was used as a reporter for transfection efficiency. The cells
were then treated with BrdU, a thymidine analog, for 2 h to
assay for DNA synthesis. The cells were fixed, and GFP-
positive cells were examined by immunofluorescence. As
shown in Figure 7A, 12% of mock transfected cells were in
S phase, and p27-transfected cells showed only 4% of cells
in S phase. In contrast, flag-Spy1 transfected cells showed
36% of cells in S phase. These controls show that p27
prevents DNA synthesis and Spy1 increases the number of
cells in S phase. When both Spy1 and p27 were cotrans-
fected, 27% of cells are in S phase, indicating that Spy1 is
able to overcome a p27-induced G1 arrest. As a control,
Figure 5. p27 and Spy1 colocalize in the nucleus. COS-1 cells were
transiently transfected with p27, myc-Spy1, or p27 plus myc-Spy1.
(A) p27 localizes to the nucleus as shown in panel a. Similarly,
myc-Spy1 localizes in the nucleus as shown in panel c. (B) Cells
transfected with both p27 and myc-Spy1 demonstrate that both
proteins localize to the nucleus (panel c). Hoechst dye was used to
stain the nucleus.
Figure 6. p27 interacts with Spy1 and CDK2. 293T cells were
transfected with the indicated constructs. The lysates were immu-
noprecipitated with -p27 or CDK2 sera and immunoblotted for
Spy1, CDK2, and p27. Lane 8 demonstrates that flag-Spy1 (top
panel), endogenous CDK2 (middle panel), and p27 (bottom panel)
can coimmunoprecipitate. The top panel of lane 11 shows that Spy1
interacts with CDK2 and that this interaction is increased when p27
is overexpressed as demonstrated in lane 12.
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Figure 7B demonstrates the approximately equal expression
levels of exogenous flag-Spy1, GFP, and p27. Taken to-
gether, the data indicate that Spy1 enhances DNA synthesis
despite p27 overexpression.
Expression of Spy1 Releases p27-inhibition of CDK2
Histone H1 Kinase Activity
Previous studies from our laboratory have shown that over-
expression of Spy1 can enhance CDK2 histone H1 kinase
activity. We wanted to determine the effect on CDK2 histone
H1 kinase activity when both p27 and Spy1 were expressed.
293T cells were transfected with mock, p27, flag-Spy1, or
both p27 and flag-Spy1. The lysates were then immunopre-
cipitated with CDK2 antisera and subjected to an in vitro
histone H1 kinase assay. Figure 8A demonstrates the basal
levels of CDK2 histone H1 kinase activity in mock-trans-
fected cells (lane 1). As expected, CDK2 activity is signifi-
cantly inhibited when p27 is overexpressed (lane 2). Cells
expressing Spy1 have a moderate increase in histone H1
kinase activity over mock, as previously demonstrated (Por-
ter et al., 2002; lane 3). Interestingly, when both p27 and Spy1
Figure 7. Spy1 can overcome a p27-induced
G1 arrest. (A) NIH3T3 wild-type cells were
transfected with the indicated constructs and
treated with BrdU for 2 h. The cells were then
fixed and examined by immunofluorescence
for BrdU incorporation by examination of
GFP-positive cells. The graphed data indicate
that there is an increase in DNA synthesis
when p27 and Spy1 are coexpressed in com-
parison to p27 alone. (B) The lysates from the
BrdU experiment were analyzed by 10% SDS-
PAGE; immunoblotting with -flag, -GFP,
and -p27 sera show approximately equiva-
lent levels of protein expression.
L.A. Porter et al.
Molecular Biology of the Cell3670
are overexpressed, histone H1 kinase activity is significantly
increased compared with p27 alone (lane 4). The data indi-
cate that Spy1 can enhance CDK2 histone H1 kinase activity
in the presence of overexpressed p27. Figure 8B shows the
expression of transfected flag-Spy1 and p27 (top and bottom
panels, respectively), as well as endogenous CDK2 in the
lysates (middle panel).
Spy1 Enhanced Proliferation Requires Endogenous
p27
To address whether Spy1 requires p27 to induce cells to
proliferate, we transiently transfected MEF cells lacking en-
dogenous p27 (MEF/) with mock, p27, myc-Spy1, or p27
plus myc-Spy1 vectors. At the 48-h time point, we found that
Spy1 expression alone did not stimulate an increase in pro-
liferation of MEF/ cells over mock, demonstrating that
endogenous p27 is an essential component in Spy1-en-
hanced proliferation (Figure 9A, mock vs. Spy1). When p27
is expressed in these cells, there is a significant decrease in
cell number, demonstrating that exogenous p27 is functional
in these cells (Figure 9A, p27). Furthermore, in the presence
of exogenous p27, Spy1 is capable of overriding the antipro-
liferative effect of p27 (Figure 9A, p27 vs. p27Spy1). This is
one representative experiment of four, all demonstrating
that p27 is an essential component of the Spy1-proliferative
pathway. Figure 9B is a Western blot of lysates from each of
the relevant samples, demonstrating that both proteins are
being expressed as indicated. However, it is interesting that
endogenous Spy1 is still capable of binding to CDK2 in cells
lacking endogenous p27 (Figure 9, C and D). Here, we
studied the interaction between endogenous Spy1 and en-
dogenous CDK2 in both wild-type NIH3T3 cells (3T3wt)
and NIH3T3 cells null for p27 (3T3/). As demonstrated
in Figure 9C, an immunoblot for -CDK2 detects CDK2 in
cell lysates as well as in Spy1 immunoprecipitations for both
cell types (top panel). The bottom panel of Figure 9C dem-
onstrates that p27 protein is only present in the 3T3wt cells.
Similarly, a Spy1 immunoblot detects Spy1 protein in cell
lysates as well as in an immunoprecipitation using CDK2
antisera (Figure 9D). Hence, Spy1 binds to CDK2 in both p27
null and wild-type 3T3 cells.
DISCUSSION
We have identified a novel interaction between p27 and
Spy1 using a yeast two-hybrid screen. This interaction was
confirmed both in vitro and in vivo using full-length p27
and Spy1 and occurs in the absence of CDK2. The binding of
Spy1 to p27 requires the same domain of p27 that mediates
direct interaction between p27 and CDK2 (Slingerland et al.,
2000).
This leads to the question: does the interaction of Spy1
with CDK2 occur independently of p27, or rather, is this an
indirect interaction mediated by p27? The answer may not
be straightforward.
In support of a p27-independent interaction, we have
shown here that Spy1 binds CDK2 in cells devoid of endog-
enous p27. This observation is consistent with prior obser-
vations that Xenopus homologues of Spy1, X-Spy1, and
p33ringo, both bind directly to CDK2 (Lenormand et al., 1999;
Karaiskou et al., 2001). In these systems Spy1 activation is
involved in triggering meiotic maturation, demonstrating
that Spy1 may have other cell cycle effects that are not
dependent on p27. Previously, we also demonstrated that
human Spy1 can exist in a complex with CDK2 (Porter et al.,
2002), although the possible involvement of p27 in this in-
teraction was not investigated.
On the other hand, a p27-dependent interaction between
Spy1 and Cdk2 is supported by the fact that p27, but not
CDK2, was detected as a positive interacting protein in a
two-hybrid screen using Spy1 as the bait. Additionally, we
show an increased association between Spy1 and CDK2
when p27 is exogenously expressed, demonstrating that p27
enhances the interaction between Spy1 and CDK2.
It is known that p27 interacts with cyclin/CDK2 com-
plexes via both its CDK and cyclin-binding regions. Con-
ceivably, when Spy1 binds to p27 it may do so by competing
with CDK2 for the CDK-binding region of p27. In this case,
however, CDK2 may still remain bound to the p27/Spy1
complex indirectly through its interaction with cyclin. This
provides one possible explanation for the presence of a
p27/Spy1/CDK2 complex. Further investigation is needed
into the functional significance of an interaction between
Spy1-and CDK2, which can be either p27-dependent or -in-
dependent.
Figure 8. Spy1 enhances histone H1 kinase activity in the presence
of p27. (A) 293T cells were transfected with the indicated constructs.
The lysates were immunoprecipitated with -CDK2 sera and sub-
jected to an in vitro kinase assay. Lane 2 shows that p27-transfected
cells have decreased kinase activity, but Spy1-transfected cells ex-
hibit kinase activity higher than mock-transfected cells (lane 3).
When both Spy1 and p27 are cotransfected, CDK2 histone H1 kinase
activity is increased as shown in lane 4 compared with p27 alone. (B)
The lysates were analyzed by 10% SDS-PAGE, transferred to nitro-
cellulose membrane, and immunoblotted with flag-Spy1, CDK2,
and p27 antisera to demonstrate equivalent protein expression.
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Figure 9. Spy1-enhanced proliferation is dependent on
endogenous p27. (A) MEF/ cells were transfected
with the indicated constructs, medium was changed
24 h posttransfection, and cells were counted via trypan
blue exclusion 48 h posttransfection. The graphed data
indicate that exogenous p27 slows proliferation in the
MEF/ cells and that Spy1 can overcome this inhibi-
tion of proliferation. Spy1 does not enhance prolifera-
tion over mock control in cells lacking endogenous p27.
The data are one representative experiment of four.
Error bars indicate the SEM of three separate transfec-
tions. (B) Lysates were analyzed by 10% SDS-PAGE,
transferred to nitrocellulose membrane, and immuno-
blotted with -myc-Spy1, and -p27 sera to demonstrate
protein expression. (C) Endogenous Spy1 was immuno-
precipitated from either NIH3T3 cells null for p27
(3T3/) or NIH3T3 wt (3T3wt). Both lysate and im-
munoprecipitated samples were separated by 10% SDS-
PAGE and immunoblotted with -CDK2 sera (top
panel) or -p27 sera (bottom panel). (D) Endogenous
CDK2 was immunoprecipitated from both 3T3wt and
3T3/ cell types. Lysate samples and the immuno-
precipitated samples were analyzed by 10% SDS-PAGE,
and immunoblotting was carried out with -Spy1 sera.
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An in vitro kinase assay was carried out to determine the
effect of coexpressing p27 and Spy1. Here, we found that
there was an increase in CDK2 histone H1 kinase activity in
the presence of Spy1 compared with p27 alone. In agreement
with these results, we demonstrate that DNA synthesis is
also increased in Spy1/p27 coexpressed cells. The data in-
dicate that expression of Spy1 can overcome CDK2 kinase
inhibition by p27. CDK2 kinase activity is required for Spy1-
proliferative effects in mammalian cells (Porter et al., 2002).
Additionally, this report demonstrates that Spy1-induced
proliferation requires endogenous p27. How might Spy1 be
enhancing CDK2 activity in a p27-dependant manner? One
possibility to investigate is whether Spy1 affects p27 degra-
dation. Total amounts of p27 are not drastically reduced
when Spy1 is coexpressed with p27, demonstrating that
Spy1 is not sufficient to target p27 for degradation, but this
observation does not rule out that Spy1 may play a role in
initiating pathways involved in p27 degradation. Explora-
tion of this possibility is ongoing.
In summary, we have identified a novel interaction be-
tween p27 and Spy1 by using a yeast two-hybrid screen. The
interaction between p27 and Spy1 was confirmed both in
vitro and in vivo in mammalian cells. Coimmunoprecipita-
tion studies demonstrated that Spy1 can bind to the CDK-
binding region, but not to the cyclin-binding region, of p27.
Additionally, CDK2 remains a part of this complex, indicat-
ing how these three proteins may interact. We demonstrate
that the interaction between Spy1 and p27 increases DNA
synthesis, indicating that Spy1 is capable of overriding p27
inhibition of CDK2 kinase activity. Furthermore, Spy1 is not
capable of enhancing proliferation in cells lacking endoge-
nous p27, demonstrating that p27 is an essential component
of the Spy1-induced cell proliferation pathway. Taken to-
gether, these data suggest that Spy1 regulates cell cycle
progression by directly interacting with p27 to relieve cell
cycle arrest.
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